Evidence map›Paper›PMID 37844941›Full record

ArticleNeurosciences (Riyadh, Saudi Arabia)2023

Incidence and risk factors of contrast-induced nephropathy in acute stroke patients undergoing computed tomography angiography: A single-center study.

Muhannad A Asiri, Mohammed S Alqahtani, Saeed A Alqahtani, Mohammed M Alwadai, Naif F Alharbi, Mohammed O Aqeeli, Saeed S Alzahrani

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurosciences (Riyadh, Saudi Arabia), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Muhannad A AsiriFrom the Neurology unit (Asiri, Alharbi, Aqeeli, Alzahrani, Alwadai), Department of Medicine, King Fahad hospital, Jeddah, from the Neurology unit (Alqahtani M), Department of Medicine, Armed Forces Hospital-Southern Region, Khamis Mushait, and from the Unit of Neurology (Alqahtani S), College of Medicine, King Khalid University, Abha, Kingdom of Saudi Arabia.ORCID https://orcid.org/0009-0006-2302-0997
Mohammed S AlqahtaniFrom the Neurology unit (Asiri, Alharbi, Aqeeli, Alzahrani, Alwadai), Department of Medicine, King Fahad hospital, Jeddah, from the Neurology unit (Alqahtani M), Department of Medicine, Armed Forces Hospital-Southern Region, Khamis Mushait, and from the Unit of Neurology (Alqahtani S), College of Medicine, King Khalid University, Abha, Kingdom of Saudi Arabia.
Saeed A AlqahtaniFrom the Neurology unit (Asiri, Alharbi, Aqeeli, Alzahrani, Alwadai), Department of Medicine, King Fahad hospital, Jeddah, from the Neurology unit (Alqahtani M), Department of Medicine, Armed Forces Hospital-Southern Region, Khamis Mushait, and from the Unit of Neurology (Alqahtani S), College of Medicine, King Khalid University, Abha, Kingdom of Saudi Arabia.
Mohammed M AlwadaiFrom the Neurology unit (Asiri, Alharbi, Aqeeli, Alzahrani, Alwadai), Department of Medicine, King Fahad hospital, Jeddah, from the Neurology unit (Alqahtani M), Department of Medicine, Armed Forces Hospital-Southern Region, Khamis Mushait, and from the Unit of Neurology (Alqahtani S), College of Medicine, King Khalid University, Abha, Kingdom of Saudi Arabia.
Naif F AlharbiFrom the Neurology unit (Asiri, Alharbi, Aqeeli, Alzahrani, Alwadai), Department of Medicine, King Fahad hospital, Jeddah, from the Neurology unit (Alqahtani M), Department of Medicine, Armed Forces Hospital-Southern Region, Khamis Mushait, and from the Unit of Neurology (Alqahtani S), College of Medicine, King Khalid University, Abha, Kingdom of Saudi Arabia.
Mohammed O AqeeliFrom the Neurology unit (Asiri, Alharbi, Aqeeli, Alzahrani, Alwadai), Department of Medicine, King Fahad hospital, Jeddah, from the Neurology unit (Alqahtani M), Department of Medicine, Armed Forces Hospital-Southern Region, Khamis Mushait, and from the Unit of Neurology (Alqahtani S), College of Medicine, King Khalid University, Abha, Kingdom of Saudi Arabia.
Saeed S AlzahraniFrom the Neurology unit (Asiri, Alharbi, Aqeeli, Alzahrani, Alwadai), Department of Medicine, King Fahad hospital, Jeddah, from the Neurology unit (Alqahtani M), Department of Medicine, Armed Forces Hospital-Southern Region, Khamis Mushait, and from the Unit of Neurology (Alqahtani S), College of Medicine, King Khalid University, Abha, Kingdom of Saudi Arabia.
Armed Forces Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the prevalence and risk factors linked to contrast-induced nephropathy in this specific patient population, aiming to ensure the highest quality of clinical care.

methodsIn a retrospective analysis, all patients who presented with an acute stroke to King Fahad Hospital, Jeddah, Emergency Department from March until November 2022 and underwent Computed Tomography Angiography (CTA) brain, Inclusion criteria were as follows: a baseline creatinine results and CTA examination performed within 24 hours of symptom onset and an available early (<5 days after CTA) follow-up creatinine result.

resultsAmong 246 stroke patients in the emergency, 182 underwent brain CTA and 8.24% had Contrast-Induced Nephropathy (CIN). intracerebral hemorrhage (ICH) increased CIN risk 7-fold (OR=6.7; 95% CI: 1.23-33.3). Abnormal baseline raised CIN risk 8-fold (OR=7.8; 95% CI: 1.74-35.1). hypertension doubled the risk for CIN (OR=2.1; 95% CI: 1.26-6.98)

conclusionThe incidence of CIN was 8.2%, particularly elevated in patients with ICH, hypertension, tissue plasminogen administration, and abnormal baseline, necessitating vigilance in managing acute stroke cases.

Indexed as

HypertensionKidney DiseasesStrokeCerebral HemorrhageComputed Tomography AngiographyContrast MediaCreatinineHumansIncidenceRetrospective StudiesRisk FactorsContrast MediaCreatinine

Identifiers

PMID37844941
PMCPMC10827032
OpenAlexW4387675074

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.